• Cytophage Technologies made an assignment in bankruptcy under Canada’s Bankruptcy and Insolvency Act, alongside its wholly owned operating subsidiary.
• Albert Gelman has been appointed as licensed insolvency trustee to administer both estates, subject to creditor affirmation.
• All independent directors resigned effective immediately; CFO James Kinley also stepped down.
• The business has ceased operations with no remaining employees aside from the CEO.
• The company expects it will miss the May 30, 2026 deadline to file first-quarter financial statements, risking a failure-to-file cease-trade order, a TSXV delisting review, and an eventual delisting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytophage Technologies Ltd. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202605221900TNWSWRCACNPR_____1kWVF6mxn) on May 22, 2026, and is solely responsible for the information contained therein.